Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments (Tables)

v3.24.1.u1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of liabilities at fair value on a recurring basis
The following tables present information about the Company’s liabilities that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicate the fair value hierarchy level of the valuation techniques and inputs that the Company utilized to determine such fair value:
March 31, 2024 Quoted Prices in Active Markets Significant Other Observable Input Significant Other Unobservable Inputs
(Level 1) (Level 2) (Level 3)
(in thousands)
Liabilities
Public Warrants $ 1,202  $ —  $ — 
Private Placement Warrants - Issued October 2019 —  —  583 
Private Placement Warrants - Issued March 2023 —  —  12,303 
Sponsor Shares —  —  1,316 
$ 1,202  $ —  $ 14,202 
December 31, 2023 Quoted Prices in Active Markets Significant Other Observable Input Significant Other Unobservable Inputs
(Level 1) (Level 2) (Level 3)
(in thousands)
Liabilities
Public Warrants $ 795  $ —  $ — 
Private Placement Warrants - Issued October 2019 —  —  583 
Private Placement Warrants - Issued March 2023 —  —  12,467 
Sponsor Shares —  —  1,304 
$ 795  $ —  $ 14,354 
Schedule of change sin the fair value of Level 3 liabilities The following is a summary of changes in the fair value of the Level 3 liabilities during the three months ended March 31, 2024:
Sponsor Shares Private Placement Warrants - Issued October 2019 Private Placement Warrants - Issued March 2023
(in thousands)
Balance as of January 1, 2024 $ 1,304  $ 583  $ 12,467 
Loss (gain) from changes in fair value
12  —  (164)
Balance as of March 31, 2024 $ 1,316  $ 583  $ 12,303